ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Jacksonville, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Jacksonville, FL, USA:

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

older who are receiving relugolix or leuprolide acetate for their prostate cancer or as adjunct to radiation therapy with a treatme...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Myovant Sciences

Jacksonville, Florida, United States and 107 other locations

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110

Phase 1, Phase 2

Arvinas
Arvinas

Fleming Island, Florida, United States and 53 other locations

of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Biological: vudalimab monotherapy
Combination Product: vudalimab + olaparib

Phase 2

Xencor
Xencor

Jacksonville, Florida, United States and 16 other locations

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Enrolling
Prostate Cancer
Device: Vanquish System
Francis Medical

Jacksonville, Florida, United States and 28 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Jacksonville, Florida, United States and 220 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Placebo
Drug: Apalutamide

Phase 3

Aragon Pharmaceuticals

Jacksonville, Florida, United States and 388 other locations

prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...

Active, not recruiting
Hormone-resistant Prostate Cancer
Stage IV Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 3

Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology

Jacksonville, Florida, United States and 538 other locations

The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA...

Enrolling
Metastatic Castration-Sensitive Prostate Cancer
Drug: Abiraterone Acetate
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Jacksonville, Florida, United States and 385 other locations

Researchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.BCR means tha ...

Enrolling
Biochemically Recurrent Prostate Cancer
Other: Placebo matching darolutamide
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 3

Bayer
Bayer

Jacksonville, Florida, United States and 257 other locations

Study CP-MGC018-03 is an open-label, two-part, Phase 2 study. Part 1 of the study will enroll participants with metastatic castration-resistant prostate...

Active, not recruiting
Anal Cancer
Small-cell Lung Cancer
Biological: vobramitamab duocarmazine
Biological: vobramitamab duocarmazine 2.0 mg (Arm A)

Phase 2

MacroGenics
MacroGenics

Jacksonville, Florida, United States and 61 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems